|
Ayala de la Peña F, Kanasaki K, Kanasaki M, Tangirala N, Maeda G, Kalluri R. Loss of p53 and acquisition of angiogenic microRNA profile are insufficient to facilitate progression of bladder urothelial carcinoma in situ to invasive carcinoma. J Biol Chem. 2011 Jun 10;286(23):20778-87. doi: 10.1074/jbc.M110.198069. Epub 2011 Mar 9. PubMed PMID: 21388952; PubMed Central PMCID: PMC3121487.
AÑO: 2011; IF: 4.773
|
21388952
|
Carmona-Bayonas A, Gómez J, González-Billalabeitia E, Canteras M, Navarrete A, Gonzálvez ML, Vicente V, Ayala de la Peña F. Prognostic evaluation of febrile neutropenia in apparently stable adult cancer patients. Br J Cancer. 2011 Aug 23;105(5):612-7. doi: 10.1038/bjc.2011.284. Epub 2011 Aug 2. PubMed PMID: 21811253; PubMed Central PMCID: PMC3188929.
AÑO: 2011; IF: 5.042
|
|
Ayala F, Dewar R, Kieran M, Kalluri R. Contribution of bone microenvironment to leukemogenesis and leukemia progression. Leukemia. 2009 Dec;23(12):2233-41. doi: 10.1038/leu.2009.175. Epub 2009 Sep 3. Review. PubMed PMID: 19727127; PubMed Central PMCID: PMC4313556.
AÑO: 2009; IF: 11.528
|
|
Zafra M, Ayala F, Gonzalez-Billalabeitia E, Vicente E, Gonzalez-Cabezas P, García T, Macías JA, Vicente V. Impact of whole-body 18F-FDG PET on diagnostic and therapeutic management of Medical Oncology patients. Eur J Cancer. 2008 Aug;44(12):1678-83. doi: 10.1016/j.ejca.2008.05.021. Epub 2008 Jul 7. PubMed PMID: 18614352.
AÑO: 2008; IF: 4.475
|
|
del Mar Osma M, Gonzalez-Billalabeitia E, Ortuño FJ, Jerez A, Ayala F, Vicente V. Transient massive peripheral blood blastosis in patient with renal clear-cell carcinoma after treatment with high-dose recombinant interleuklin-2. Lancet Oncol. 2007 Mar;8(3):275-6. PubMed PMID: 17329199.
AÑO: 2007; IF: 12.247
|